Blackstone and TPG to Acquire Hologic for $18.3 Billion, Marking Largest MedTech Deal in Nearly Two Decades
In a landmark move in the medical diagnostics sector, private equity firms Blackstone and TPG have announced plans to acquire Hologic, Inc., a leading medical technology company specializing in women's health diagnostics, for up to
In a landmark move in the medical diagnostics sector, private equity firms Blackstone and TPG have announced plans to acquire Hologic, Inc., a leading medical technology company specializing in women’s health diagnostics, for up to $18.3 billion, including debt. This deal represents the largest acquisition in the medical devices industry since Boston Scientific’s purchase of Guidant Corp. in 2006
Under the terms of the agreement, Hologic shareholders will receive $76 per share in cash, plus a potential additional $3 through a contingent value right, contingent on the achievement of certain milestones. The acquisition is subject to regulatory approvals and is expected to be finalized in the coming months.
Hologic, headquartered in the United States, is renowned for its innovative diagnostic solutions, particularly in breast and cervical cancer screening. The company’s products are widely used in hospitals and clinics globally, including in India, where there is a growing demand for advanced diagnostic technologies.
The acquisition underscores the increasing interest in the medical diagnostics sector, driven by the rising global focus on healthcare quality and early disease detection. Blackstone and TPG’s investment is expected to accelerate Hologic’s growth and innovation in the diagnostics field.
